Loading…
Loading…
PSY (Defiance Next Gen Altered Experience ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.
Is PSY's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Toronto, Ontario--(Newsfile Corp. - August 10, 2026) - Vlad Tasevski, Chief Innovation Officer, Purpose Investments Inc. ("Purpose Investments") and his team, joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange ("TSX"), to open the market to celebrate the launch of their new ETF: Purpose Structured Equity Yield Fund (TSX: PSY) Cannot view this video? Visit: https://www.youtube.com/watch?v=6qkV5ILWz3o Now available in an ETF series, PSY combines actively managed derivatives with a broad portfolio of North American and global securities to generate tax efficient monthly income with contingent protection against moderate market declines.
On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows.
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched.
Psychedelic substances are often grouped together with cannabis, but there are some important distinctions. ATAI, CMPS and FTRP are some of the best stocks in the space.
No matter what comes next, there will be an ETF for it.